Filtros de búsqueda

Lista de obras de William Hope

A PCR method for the identification of methicillin-resistant Staphylococcus aureus (MRSA) from screening swabs

artículo científico publicado en 2004

A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants with Invasive Candidiasis.

artículo científico publicado en 2018

A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis

A systematic review of clinical decision support systems for antimicrobial management: are we failing to investigate these interventions appropriately?

artículo científico publicado en 2017

AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial

artículo científico publicado en 2015

AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial

artículo científico publicado en 2018

Achieving target voriconazole concentrations more accurately in children and adolescents

artículo científico publicado en 2015

Amphotericin B Penetrates into the Central Nervous System Through Focal Disruption of the Blood Brain Barrier in Experimental Hematogenous Candida Meningoencephalitis

artículo científico publicado en 2019

An invertebrate model to evaluate virulence in Aspergillus fumigatus: the role of azole resistance.

artículo científico publicado en 2014

Anidulafungin for neonatal hematogenous Candida meningoencephalitis: identification of candidate regimens for humans using a translational pharmacological approach.

artículo científico publicado en 2011

Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective

artículo científico publicado en 2013

Antifungal pharmacokinetics and pharmacodynamics: bridging from the bench to bedside

artículo científico publicado en 2009

Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development

artículo científico publicado en 2015

Aspergillus

Assessing candiduria in a critically ill patient

artículo científico publicado en 2009

Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.

artículo científico publicado en 2013

CSF penetration of vancomycin in critical care patients with proven or suspected ventriculitis: a prospective observational study

scientific article published on 01 April 2019

Can We Achieve Clinical Breakpoints for the Triazoles in Aspergillosis?

Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis

artículo científico publicado en 2008

Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study.

artículo científico publicado en 2016

Changes in the incidence of candidiasis in neonatal intensive care units

artículo científico publicado en 2014

Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis ⬇️

artículo científico publicado en 2006

Clinical pharmacology of antifungal agents in pediatrics: children are not small adults

artículo científico

Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.

artículo científico publicado en 2006

Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with haematological malignancies

scientific article published on 19 August 2018

Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis

artículo científico publicado en 2017

Combination of voriconazole and anidulafungin for treatment of triazole-resistant aspergillus fumigatus in an in vitro model of invasive pulmonary aspergillosis ⬇️

artículo científico publicado en 2012

Combination therapy for carbapenemase-producing Entero-bacteriaceae: INCREMENT-al effect on resistance remains unclear.

artículo científico publicado en 2017

Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis

artículo científico publicado en 2009

Comparison of piperacillin exposure in the lungs of critically ill patients and healthy volunteers.

artículo científico publicado en 2018

Comparison of the accuracy and precision of pharmacokinetic equations to predict free meropenem concentrations in critically ill patients

artículo científico publicado en 2014

Considerations for effect site pharmacokinetics to estimate drug exposure: concentrations of antibiotics in the lung

artículo científico publicado en 2017

Correction for Stott et al., "Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis"

scholarly article by Katharine E Stott et al published December 2018 in Antimicrobial Agents and Chemotherapy

Correction for Stott et al., "Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis"

scholarly article by Katharine E Stott et al published December 2018 in Antimicrobial Agents and Chemotherapy

Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial

artículo científico publicado en 2019

Delivering precision antimicrobial therapy through closed-loop control systems

artículo científico publicado en 2017

Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effect

artículo científico publicado en 2006

Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations

artículo científico publicado en 2012

Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis

scientific article published on 28 January 2019

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.

artículo científico publicado en 2014

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi.

artículo científico publicado en 2014

ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others.

artículo científico publicado en 2014

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT).

artículo científico publicado en 2012

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases.

artículo científico publicado en 2012

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.

artículo científico publicado en 2012

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

artículo científico publicado en 2012

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS.

artículo científico publicado en 2012

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.

artículo científico publicado en 2012

EUCAST Technical note on Amphotericin B ⬇️

artículo científico publicado el 19 de octubre de 2011

EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole

artículo científico publicado en 2014

EUCAST technical note on anidulafungin

artículo científico publicado en 2011

EUCAST technical note on posaconazole ⬇️

artículo científico publicado el 16 de septiembre de 2011

EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST) ⬇️

artículo científico publicado el 8 de mayo de 2012

EUCAST technical note on voriconazole and Aspergillus spp.

artículo científico publicado en 2013

Effect of neutropenia and treatment delay on the response to antifungal agents in experimental disseminated candidiasis

artículo científico publicado en 2006

Efficacy and safety of posaconazole for chronic pulmonary aspergillosis

artículo científico publicado en 2010

Efficacy of an abbreviated induction regimen of amphotericin B deoxycholate for cryptococcal meningoencephalitis: 3 days of therapy is equivalent to 14 days.

artículo científico publicado en 2014

Endpoint Assessment in Rabbit Models of Invasive Pulmonary Aspergillosis and Mucormycosis

artículo científico publicado en 2017

Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infections

artículo científico

Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis

artículo científico publicado en 2017

Exploring the Use of C-Reactive Protein to Estimate the Pharmacodynamics of Vancomycin.

artículo científico publicado en 2018

Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials

artículo científico publicado en 2018

Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi.

artículo científico publicado en 2017

F901318 represents a novel class of antifungal drug that inhibits dihydroorotate dehydrogenase.

artículo científico publicado en 2016

FDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug Development

artículo científico publicado en 2020

First dose in neonates: are juvenile mice, adults and in vitro-in silico data predictive of neonatal pharmacokinetics of fluconazole

artículo científico publicado en 2014

Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance

artículo científico publicado en 2019

Fluconazole loading dose pharmacokinetics and safety in infants

artículo científico publicado en 2011

Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation

artículo científico publicado en 2014

Galactomannan antigen detection in the diagnosis of invasive aspergillosis

artículo científico publicado en 2007

Gene expression profiles of human dendritic cells interacting with Aspergillus fumigatus in a bilayer model of the alveolar epithelium/endothelium interface

artículo científico publicado en 2014

Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans

scientific article published on 25 April 2019

Guidelines need controls

artículo científico publicado en 2015

Higher than standard meropenem and linezolid dosages needed for appropriate treatment of an intracerebral hemorrhage patient with augmented renal clearance

scholarly article by Pier Giorgio Cojutti et al published 29 April 2018 in European Journal of Clinical Pharmacology

How severe is antibiotic pharmacokinetic variability in critically ill patients and what can be done about it?

artículo científico

How to design a study to evaluate therapeutic drug monitoring in infectious diseases?

artículo científico publicado en 2020

Impact of Bolus dosing versus continuous infusion of Piperacillin and Tazobactam on the development of antimicrobial resistance in Pseudomonas aeruginosa.

artículo científico publicado en 2013

Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.

artículo científico publicado en 2017

Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial

artículo científico publicado en 2017

In vitro model of invasive pulmonary aspergillosis in the human alveolus

artículo científico publicado en 2012

In vitro susceptibility of Aspergillus fumigatus to isavuconazole: correlation with itraconazole, voriconazole, and posaconazole.

artículo científico publicado en 2013

Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use.

artículo científico publicado en 2002

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

artículo científico publicado en 2014

Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy ⬇️

artículo científico publicado en 2014

Intermittent Dosing of Micafungin Is Effective for Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits

artículo científico publicado en 2015

Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial

artículo científico publicado en 2020

Invasion of the alveolar-capillary barrier by Aspergillus spp.: therapeutic and diagnostic implications for immunocompromised patients with invasive pulmonary aspergillosis

artículo científico publicado en 2009

Invasive aspergillosis: current and future challenges in diagnosis and therapy

artículo científico publicado en 2004

Invasive fungal infections

artículo científico

Invasive pulmonary aspergillosis with spontaneous resolution and the diagnostic utility of PCR from tissue specimens

artículo científico publicado en 2004

Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study)

artículo científico publicado en 2016

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

artículo científico publicado en 2015

Isavuconazonium sulfate: a new agent for the treatment of invasive aspergillosis and invasive mucormycosis

artículo científico publicado en 2016

Isolation of Aspergillus species from the airway of lung transplant recipients is associated with excess mortality

artículo científico publicado en 2012

Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections

artículo científico

Laboratory diagnosis of invasive aspergillosis.

artículo científico publicado en 2005

Linezolid underexposure in a patient co-treated with venlafaxine.

artículo científico publicado en 2015

Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions

artículo científico publicado en 2016

Metallo-β-lactamases: structure, function, epidemiology, treatment options, and the development pipeline

artículo científico publicado en 2020

Methodological features of clinical pharmacokinetic-pharmacodynamic studies of antibacterials and antifungals: a systematic review

artículo científico publicado en 2020

Molecular mechanisms of primary resistance to flucytosine in Candida albicans

artículo científico publicado en 2004

Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients

scientific article published in 2011

Observational study of the clinical efficacy of voriconazole and its relationship to plasma concentrations in patients

artículo científico publicado en 2011

Opinion: the pharmacometrics of infectious disease

artículo científico publicado en 2013

Optimising antifungal therapy for individual patients

artículo científico publicado en 2004

Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosing

artículo científico publicado en 2007

Optimizing management of invasive mould diseases.

artículo científico publicado en 2011

Optimizing micafungin dosing in children

artículo científico publicado en 2012

Outcomes by Minimum Inhibitory Concentrations for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials

scientific article published on 21 December 2018

PHARMACOKINETICS OF ORALLY ADMINISTERED VORICONAZOLE IN AFRICAN PENGUINS (SPHENISCUS DEMERSUS) AFTER SINGLE AND MULTIPLE DOSES.

artículo científico publicado en 2017

Pharmacodynamics for antifungal drug development: an approach for acceleration, risk minimization and demonstration of causality.

artículo científico publicado en 2016

Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy

artículo científico publicado en 2016

Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum Beta Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia caused by ESBL-Producing Klebsiella pneumoniae

scientific article published on 06 April 2020

Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response

artículo científico publicado en 2017

Pharmacodynamics of Isavuconazole in a Dynamic In Vitro Model of Invasive Pulmonary Aspergillosis

artículo científico publicado en 2015

Pharmacodynamics of Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis

scientific article published on 23 August 2019

Pharmacodynamics of Posaconazole in Experimental Invasive Pulmonary Aspergillosis: Utility of Serum Galactomannan as a Dynamic Endpoint of Antifungal Efficacy

artículo científico publicado en 2020

Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections

scientific article published on 25 July 2019

Pharmacodynamics of Voriconazole for Invasive Pulmonary Scedosporiosis. ⬇️

artículo científico publicado en 2018

Pharmacodynamics of Voriconazole in Children: Further Steps along the Path to True Individualized Therapy

artículo científico publicado en 2016

Pharmacodynamics of amphotericin B deoxycholate, amphotericin B lipid complex, and liposomal amphotericin B against Aspergillus fumigatus

artículo científico publicado en 2015

Pharmacodynamics of echinocandins against Candida glabrata: requirement for dosage escalation to achieve maximal antifungal activity in neutropenic hosts

artículo científico publicado en 2011

Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance

artículo científico publicado en 2015

Pharmacodynamics of isavuconazole in experimental invasive pulmonary aspergillosis: implications for clinical breakpoints

artículo científico publicado en 2016

Pharmacodynamics of itraconazole against Aspergillus fumigatus in an in vitro model of the human alveolus: perspectives on the treatment of triazole-resistant infection and utility of airway administration.

artículo científico publicado en 2012

Pharmacodynamics of liposomal amphotericin B and flucytosine for cryptococcal meningoencephalitis: safe and effective regimens for immunocompromised patients.

artículo científico publicado en 2013

Pharmacodynamics of teicoplanin against MRSA.

artículo científico publicado en 2017

Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus.

artículo científico publicado en 2017

Pharmacodynamics of the Orotomides against Aspergillus fumigatus: New Opportunities for Treatment of Multidrug-Resistant Fungal Disease

artículo científico publicado en 2017

Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates

artículo científico publicado en 2016

Pharmacodynamics of voriconazole in a dynamic in vitro model of invasive pulmonary aspergillosis: implications for in vitro susceptibility breakpoints.

artículo científico publicado en 2012

Pharmacokinetics and Concentration-Dependent Efficacy of Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis

artículo científico publicado en 2016

Pharmacokinetics and pharmacodynamics of a novel triazole, isavuconazole: mathematical modeling, importance of tissue concentrations, and impact of immune status on antifungal effect

artículo científico publicado en 2009

Pharmacokinetics and pharmacodynamics of amphotericin B deoxycholate, liposomal amphotericin B, and amphotericin B lipid complex in an in vitro model of invasive pulmonary aspergillosis

artículo científico publicado en 2010

Pharmacokinetics and pharmacodynamics of anidulafungin for experimental Candida endophthalmitis: insights into the utility of echinocandins for treatment of a potentially sight-threatening infection.

artículo científico publicado en 2012

Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints

scientific article published on 09 April 2013

Pharmacokinetics and pharmacodynamics of posaconazole for invasive pulmonary aspergillosis: clinical implications for antifungal therapy

artículo científico publicado en 2011

Pharmacokinetics of an elevated dosage of micafungin in premature neonates

artículo científico publicado en 2009

Pharmacokinetics–pharmacodynamics of antifungal agents in the central nervous system

artículo científico publicado en 2018

Plasma and peritoneal fluid population pharmacokinetics of micafungin in post-surgical patients with severe peritonitis

artículo científico publicado en 2015

Plasma and target-site subcutaneous tissue population pharmacokinetics and dosing simulations of cefazolin in post-trauma critically ill patients

artículo científico publicado en 2015

Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis.

artículo científico publicado en 2018

Population Pharmacokinetic Modeling of VL-2397, a Novel Systemic Antifungal Agent: Analysis of a Single- and Multiple-Ascending-Dose Study in Healthy Subjects

artículo científico publicado en 2019

Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis

scholarly article by Katharine E Stott et al published September 2018 in Antimicrobial Agents and Chemotherapy

Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function

artículo científico publicado en 2016

Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy.

artículo científico publicado en 2016

Population Pharmacokinetics of Anidulafungin in Critically Ill Patients

scientific article published on 24 June 2019

Population Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Children

artículo científico publicado en 2016

Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women infected with Schistosoma japonicum

artículo científico publicado en 2020

Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies

artículo científico publicado en 2017

Population pharmacokinetics and pharmacodynamics of fosfomycin in non–critically ill patients with bacteremic urinary infection caused by multidrug-resistant Escherichia coli

scientific article published on 10 April 2018

Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy

artículo científico publicado en 2016

Population pharmacokinetics of continuous-infusion ceftazidime in febrile neutropenic children undergoing HSCT: implications for target attainment for empirical treatment against Pseudomonas aeruginosa

artículo científico publicado en 2019

Population pharmacokinetics of conventional and intermittent dosing of liposomal amphotericin B in adults: a first critical step for rational design of innovative regimens

artículo científico publicado en 2012

Population pharmacokinetics of extended-infusion piperacillin-tazobactam in hospitalized patients with nosocomial infections

artículo científico publicado en 2012

Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp

artículo científico publicado en 2018

Population pharmacokinetics of micafungin and its metabolites M1 and M5 in children and adolescents

artículo científico publicado en 2014

Population pharmacokinetics of micafungin in neonates and young infants

artículo científico publicado en 2010

Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing

artículo científico publicado en 2007

Population pharmacokinetics of teicoplanin in children

artículo científico publicado en 2014

Population pharmacokinetics of voriconazole in adults

artículo científico publicado en 2011

Posaconazole: the case for therapeutic drug monitoring.

artículo científico

Prognostic value of galactomannan: current evidence for monitoring response to antifungal therapy in patients with invasive aspergillosis

artículo científico publicado en 2017

Pulmonary penetration of piperacillin and tazobactam in critically ill patients.

artículo científico publicado en 2014

Reply to Asempa et al., "The Zinc Conundrum: Meropenem Activity against NDM-Harboring Enterobacteriaceae"

scientific article published on 23 November 2020

Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease.

artículo científico publicado en 2018

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

scientific article published on June 2008

Safety and pharmacokinetics of multiple-dose anidulafungin in infants and neonates

artículo científico publicado en 2011

Safety and pharmacokinetics of repeat-dose micafungin in young infants

artículo científico publicado en 2009

Safety, Tolerability, and Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Pediatric Patients

artículo científico publicado en 2016

Sequential infection with Nocardia farcinica and Cryptococcus neoformans var. gattii in an immunocompetent host

artículo científico publicado en 2003

Setting Our Sights on Infectious Diseases

scientific article published on 06 December 2019

Short-course High-dose Liposomal Amphotericin B for Human Immunodeficiency Virus–associated Cryptococcal Meningitis: A Phase 2 Randomized Controlled Trial

artículo científico publicado en 2018

Software for Dosage Individualization of Voriconazole: a Prospective Clinical Study

scientific article published on 27 March 2019

Software for dosage individualization of voriconazole for immunocompromised patients

artículo científico publicado en 2013

Suboptimal Exposure to Anti-TB Drugs in a TBM/HIV+ Population is not Related to Anti-retroviral Therapy

artículo científico publicado en 2017

Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 1

artículo científico publicado en 2016

Suppression of Emergence of Resistance in Pathogenic Bacteria: Keeping Our Powder Dry, Part 2

artículo científico publicado en 2016

Surface response modeling to examine the combination of amphotericin B deoxycholate and 5-fluorocytosine for treatment of invasive candidiasis

artículo científico publicado en 2005

The Potential Role of Fosfomycin in Neonatal Sepsis Caused by Multidrug-Resistant Bacteria

artículo científico publicado en 2017

The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) β-d-glucan and consequences of delayed antifungal therapy

artículo científico publicado en 2010

The invasive and saprophytic syndromes due to Aspergillus spp.

artículo científico publicado en 2005

The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates

artículo científico publicado en 2008

The pharmacology and clinical use of caspofungin

artículo científico publicado en 2007

Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology

scientific article published on 29 December 2013

Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations

artículo científico publicado en 2017

Therapeutic drug monitoring for triazoles

scientific article published on December 2008

Therapeutic drug monitoring of beta-lactams for critically ill patients: unwarranted or essential?

artículo científico publicado en 2010

Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for?

artículo científico publicado en 2015

Therapy for fungal diseases: opportunities and priorities

scientific article published on 06 March 2010

Tissue Distribution and Elimination of Isavuconazole following Single and Repeat Oral-Dose Administration of Isavuconazonium Sulfate to Rats.

artículo científico publicado en 2017

Tissue penetration of antifungal agents.

artículo científico publicado en 2014

Tools for the Individualized Therapy of Teicoplanin for Neonates and Children.

artículo científico publicado en 2017

Toxicodynamics of itraconazole: implications for therapeutic drug monitoring

artículo científico publicado en 2009

Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model

scientific article published on 01 August 2019

Urine D-arabinitol/L-arabinitol ratio in diagnosing Candida infection in patients with haematological malignancy and HIV infection

artículo científico publicado en 2002

Vancomycin therapy in secondary care; investigating factors that impact therapeutic target attainment.

artículo científico publicado en 2016

Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda